Datasea Lists NeuroVibe as FDA Class II Biofeedback Device
Beijing, China, August,11, 2026 Datasea Intelligent Technology Ltd. has announced that its variable interest entity, Shuhai Jingwei (Shenzhen) Information...
neurotechnology
Advertisement
CraniUS Secures NIH Grant for Glioblastoma Therapy
BALTIMORE, June 29, 2026 CraniUS Therapeutics has received an initial $1.1 million award through the National Institutes of Health...
Orion Pharma Expands Europe Biosimilar Portfolio with Shilpa
ESPOO, Finland, June 30, 2026 Orion Pharma has announced a strategic agreement with Shilpa Biologicals Private Limited, a wholly...
Aurenar Wins FDA Breakthrough Device Status for V-Link™
ST. LOUIS, Mo., June 30, 2026 Aurenar has announced that the U.S. Food and Drug Administration (FDA) has granted...
NIH Study Reveals Brain Cells Driving Human Speech Activity
BETHESDA, Md., June 20, 2026 Researchers supported by the National Institutes of Health (NIH) have achieved a groundbreaking milestone...
Advertisements
SonoClear Study Selected for EANS 2026 Oral Presentation
OSLO, Norway, June 16, 2026 SonoClear AS has announced that findings from its pivotal multicenter study evaluating the SonoClear®...
Nervonik Completes First Human Nerve Sensing Study
LOS ANGELES, June 16, 2026 Nervonik Inc., a clinical-stage medical device company focused on next-generation neuromodulation technologies, has announced...
Datasea Advances FDA Compliance for Acoustic BCI Device
BEIJING, China, June 12, 2026 Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) has announced a significant step forward in its...
Wave Neuroscience Wins FDA Clearance for MeRT in PTSD
NEWPORT BEACH, Calif., June 11, 2026 Wave Neuroscience announced that the U.S. Food and Drug Administration (FDA) has granted...
Cala Health Gains FDA Clearance for kIQ Plus Device
San Mateo, California & Chicago, Illinois, U.S. | April 15, 2026 Cala Health has announced a major regulatory milestone...
Advertisement
